Physician profile
Roger Thomas
NPI 1669952354
$2,136.86
in general payments reported to CMS, 2019-2025
19 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $496 · 2022: $595 · 2023: $271 · 2024: $381 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,046.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $431.76 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $278.69 | 2024-2025 | Cobenfy |
| Lundbeck LLC | $253.58 | 2021-2024 | Abilify Maintena, Rexulti |
| Biohaven Pharmaceutical Holding Company Ltd. | $203.90 | 2022 | |
| Janssen Pharmaceuticals, INC | $151.70 | 2023-2025 | Invega Sustenna, Spravato |
| Amgen INC. | $149.56 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $124.18 | 2023-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $99.44 | 2023-2024 | Caplyta |
| Collegium Pharmaceutical, INC. | $94.51 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $60.69 | 2025 | Uzedy |
| Biodelivery Sciences International, INC. | $52.75 | 2021 | |
| Corium, LLC | $46.90 | 2023 | Azstarys |
| Axsome Therapeutics, INC. | $41.98 | 2024 | Auvelity |
| Scilex Pharmaceuticals INC. | $40.37 | 2021-2022 | |
| Alkermes, INC. | $33.81 | 2024-2025 | Aristada, Lybalvi |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $19.59 | 2022 | |
| Grt US Holding, INC. | $18.86 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $18.73 | 2021 | |
| Almatica Pharma LLC | $15.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.